Boyer O - Search Results

1

A phase I/II study of herpes simplex virus type 1 thymidine kinase "suicide" gene therapy for recurrent glioblastoma. Study Group on Gene Therapy for Glioblastoma.

Klatzmann D, Valéry CA, Bensimon G, Marro B, Boyer O, Mokhtari K, Diquet B, Salzmann JL, Philippon J. Klatzmann D, et al. Among authors: boyer o. Hum Gene Ther. 1998 Nov 20;9(17):2595-604. doi: 10.1089/hum.1998.9.17-2595. Hum Gene Ther. 1998. PMID: 9853526 Clinical Trial.

2

A phase I/II dose-escalation study of herpes simplex virus type 1 thymidine kinase "suicide" gene therapy for metastatic melanoma. Study Group on Gene Therapy of Metastatic Melanoma.

Klatzmann D, Chérin P, Bensimon G, Boyer O, Coutellier A, Charlotte F, Boccaccio C, Salzmann JL, Herson S. Klatzmann D, et al. Among authors: boyer o. Hum Gene Ther. 1998 Nov 20;9(17):2585-94. doi: 10.1089/hum.1998.9.17-2585. Hum Gene Ther. 1998. PMID: 9853525 Clinical Trial.

3

Immunological defects after suicide gene therapy of experimental graft-versus-host disease.

Cohen JL, Lacroix-Desmazes S, Charlotte F, Lejeune L, Martin PJ, Klatzmann D, Boyer O. Cohen JL, et al. Among authors: boyer o. Hum Gene Ther. 1999 Nov 1;10(16):2701-7. doi: 10.1089/10430349950016744. Hum Gene Ther. 1999. PMID: 10566898

4

Transient control of a virus-induced immunopathology by genetic immunosuppression.

Boyer O, Cohen JL, Bellier B, Thomas-Vaslin V, Klatzmann D, Saron MF. Boyer O, et al. Gene Ther. 2000 Sep;7(18):1536-42. doi: 10.1038/sj.gt.3301276. Gene Ther. 2000. PMID: 11021591

5

Preservation of graft-versus-infection effects after suicide gene therapy for prevention of graft-versus-host disease.

Cohen JL, Saron MF, Boyer O, Thomas-Vaslin V, Bellier B, Lejeune L, Charlotte F, Klatzmann D. Cohen JL, et al. Among authors: boyer o. Hum Gene Ther. 2000 Dec 10;11(18):2473-81. doi: 10.1089/10430340050207966. Hum Gene Ther. 2000. PMID: 11119419

6

T-Cell suicide gene therapy for organ transplantation: induction of long-lasting tolerance to allogeneic heart without generalized immunosuppression.

Braunberger E, Cohen JL, Boyer O, Pegaz-Fiornet B, Raynal-Raschilas N, Bruneval P, Thomas-Vaslin V, Bellier B, Carpentier A, Glotz D, Klatzmann D. Braunberger E, et al. Among authors: boyer o. Mol Ther. 2000 Dec;2(6):596-601. doi: 10.1006/mthe.2000.0208. Mol Ther. 2000. PMID: 11124060 Free article.

7

Extent of tumor-brain interface: a new tool to predict evolution of malignant gliomas.

Valéry CA, Marro B, Boyer O, Duyme M, Mokhtari K, Marsault C, Klatzmann D, Philippon J. Valéry CA, et al. Among authors: boyer o. J Neurosurg. 2001 Mar;94(3):433-6. doi: 10.3171/jns.2001.94.3.0433. J Neurosurg. 2001. PMID: 11235948 Clinical Trial.

8

Suicide gene therapy of graft-versus-host disease: immune reconstitution with transplanted mature T cells.

Cohen JL, Boyer O, Klatzmann D. Cohen JL, et al. Among authors: boyer o. Blood. 2001 Oct 1;98(7):2071-6. doi: 10.1182/blood.v98.7.2071. Blood. 2001. PMID: 11567992 Free article.

9

Effect of combined cytostatic cyclosporin A and cytolytic suicide gene therapy on the prevention of experimental graft-versus-host disease.

Maury S, Litvinova E, Boyer O, Benard L, Bruel S, Klatzmann D, Cohen JL. Maury S, et al. Among authors: boyer o. Gene Ther. 2002 Feb;9(3):201-7. doi: 10.1038/sj.gt.3301637. Gene Ther. 2002. PMID: 11859423

10

Long-term survival after gene therapy for a recurrent glioblastoma.

Valéry CA, Seilhean D, Boyer O, Marro B, Hauw JJ, Kemeny JL, Marsault C, Philippon J, Klatzmann D. Valéry CA, et al. Among authors: boyer o. Neurology. 2002 Apr 9;58(7):1109-12. doi: 10.1212/wnl.58.7.1109. Neurology. 2002. PMID: 11940704

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

388 results

Search Page

Filters